サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452565

北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム：2030年までの市場予測 - 地域別分析 - 製品別、用途別、エンドユーザー別

North America Fluorescence In-Situ Hybridization Imaging Systems Market Forecast to 2030 - Regional Analysis - By Product, Application, and End User

出版日
ページ情報
英文 93 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム：2030年までの市場予測 - 地域別分析 - 製品別、用途別、エンドユーザー別
出版日: 2024年01月04日
発行: The Insight Partners
ページ情報: 英文 93 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場は、2022年の5億700万米ドルから2030年には8億8,540万米ドルに成長すると予測されています。2022年から2030年までのCAGRは7.2%と推定されます。

魚類画像化技術の自動化とデジタル化が北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム市場を後押し

自動FISH計数システムは、ホルマリン固定パラフィン包埋ヒト組織標本中の間期核から発生するFISHシグナルの自動検出と計数を容易にします。このシステムは、自動走査型顕微鏡や画像解析システムを含む標準的なハードウェア・コンポーネントと、FISHアッセイに特化したアプリケーション（アプリ）を備えたソフトウェア・プラットフォームから構成されます。自動FISH列挙システムは、IVD目的のFISHアッセイとともに使用され、細胞のサイズ、形状、色に基づいて細胞を同定、計数、分類するように設計されています。自動化技術を採用することで、手作業によるFISH検査列挙システムと比較して、作業時間が短縮される可能性があります。FISHは、使いやすさとサンプル採取後即日結果を提供できる能力により、診断のためのゴールドスタンダードな方法です。プローブ量を減らし、作業時間を短縮したFISHイメージングの自動化は、臨床および研究検査室におけるFISH検査の適用を間もなくさらに促進し、最終的に患者の転帰を改善する可能性が高いです。FISHイメージングをデジタル病理学プラットフォームと統合すれば、専門家同士の遠隔コラボレーションが容易になり、テレパソロジーの道が開けると思われます。イメージング技術の進歩により、より高解像度のイメージング、改良された蛍光色素、洗練された画像解析アルゴリズムが生まれ、正確な遺伝子の可視化が促進され、FISHイメージングツールが強化されるであろう。将来、FISH技術は個別化医療において重要な役割を果たすと予想され、個々の遺伝子プロファイルに基づいた治療戦略の調整を支援します。AIと機械学習の統合は、膨大なデータセットからの洞察を提供し、病気の転帰を予測することで、FISHイメージングの診断の可能性をさらに増幅させると思われます。このように、自動化とデジタル化は、蛍光in situハイブリダイゼーション（FISH）イメージング・システム市場の重要な動向として浮上する可能性が高いです。

北米の蛍光in situハイブリダイゼーション（FISH）イメージングシステム市場概要

北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場は、米国、カナダ、メキシコに区分されます。対象疾患の有病率の増加は、臨床的緊急代替の必要性を推進し、この地域の市場成長を促進します。分子遺伝学や細胞遺伝学における高度な診断ツールに対する需要の高まり、遺伝性疾患やがんの有病率の上昇が、蛍光in-situハイブリダイゼーション（FISH）イメージングシステムの採用に拍車をかけています。米国がん協会が2022年に発表したデータによると、米国では約190万人が新たにがんと診断され、60万9360人ががんで死亡しています。これらのシステムは遺伝物質の高解像度イメージングを提供し、研究者や臨床医がより高い精度で染色体異常や遺伝子変異を検出することを可能にします。さらに、個別化医療と標的療法への注目の高まりは、遺伝子解析を伴う研究活動の急増につながり、FISHイメージング・システムの需要を高めています。細胞内の遺伝子配列に関する詳細な空間情報を直接提供するこれらのシステムの能力は、研究および臨床アプリケーションの両方において非常に貴重であることが証明されています。自動化、スループットの向上、画像解析ソフトウェアの強化など、FISHイメージング・システムの技術的進歩の人気も近年高まっています。その結果、研究所や医療機関は、より大量のサンプルを処理し、正確な結果を効率的に生成するための設備が整ってきています。

北米の蛍光in-situハイブリダイゼーション（フィッシュ）イメージング・システム市場の収益と2030年までの予測（金額）

北米の蛍光in-situハイブリダイゼーション（魚）イメージングシステム市場セグメンテーション

北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場は、製品、用途、エンドユーザー、国にセグメント化されます。

製品別では、北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場は、機器、消耗品、アクセサリー、ソフトウェアに区分されます。2022年の北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場では、消耗品セグメントが最大シェアを占めています。

用途別では、北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場は、がん診断、遺伝病診断、感染症診断、その他に区分されます。2022年の北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場では、がん診断分野が最大シェアを占めています。

エンドユーザー別では、北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場は、診断ラボ、契約研究機関、製薬・バイオテクノロジー企業、その他に区分されます。2022年の北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場では、診断ラボ部門が最大シェアを占めました。

国別では、北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場は、米国、カナダ、メキシコに区分されます。2022年の北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム市場は米国が独占しています。

Euroclone SpA、TissueGnostics GmbH、Agilent Technologies Inc、Abnova Taiwan Corp、BioGenex Laboratories Inc、Leica Biosystems Nussloch GmbH、MetaSystems Probes GmbH、Bio-View Ltd、Thermo Fisher Scientific Inc、Applied Spectral Imagingは、北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場で事業展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム市場- 主要産業力学

  • 主な市場促進要因
    • 対象疾患の有病率の上昇
    • 体外診断への研究開発投資の増加
  • 主な市場抑制要因
    • FISHイメージング・システムと手順の高コスト
  • 主な市場機会
    • 蛍光in situハイブリダイゼーションイメージングの技術進歩
  • 今後の動向
    • FISHイメージング技術の自動化とデジタル化
  • インパクト分析

第5章 蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場：北米市場分析

  • 北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム市場収益、2022年～2030年

第6章 北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム市場-2030年までの収益と予測：製品別

  • 市場収益シェア（%）：2022年・2030年
  • 機器
  • 消耗品
  • 付属品
  • ソフトウェア

第7章 北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場-2030年までの収益と予測：用途別

  • 市場収益シェア（%）：2022年・2030年
  • がん診断
  • 遺伝子疾患診断
  • 感染症診断
  • その他

第8章 北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム市場-2030年までの収益と予測：エンドユーザー別

  • 市場収益シェア（%）：2022年・2030年
  • 診断研究所
  • 契約研究機関
  • 製薬・バイオテクノロジー企業
  • その他

第9章 北米の蛍光In-Situハイブリダイゼーション（FISH）イメージングシステム市場：国別分析

    • 北米、国別、2022年および2030年（%）
      • 米国
      • カナダ
      • メキシコ

第10章 北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場業界情勢

  • 北米の蛍光in-situハイブリダイゼーション（FISH）イメージングシステム市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • TissueGnostics GmbH
  • Agilent Technologies Inc
  • BioGenex Laboratories Inc
  • Leica Biosystems Nussloch GmbH
  • MetaSystems Probes GmbH
  • Bio-View Ltd
  • Thermo Fisher Scientific Inc
  • Applied Spectral Imaging
  • PerkinElmer Inc
  • Euroclone SpA

第12章 付録

図表

List Of Tables

  • Table 1. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation
  • Table 2. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Recent Inorganic Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • Table 18. Recent Organic Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • Table 19. Glossary of Terms, North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

List Of Figures

  • Figure 1. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation, By Country
  • Figure 2. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 6. Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Accessories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Software: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 11. Cancer Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Genetic Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Infectious Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 16. Diagnostic Laboratories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Contract Research Organization: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnological Companies: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 21. North America , by Country, 2022 & 2030 (%)
  • Figure 22. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
目次
Product Code: BMIRE00029256

The North America fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 507.0 million in 2022 to US$ 885.4 million by 2030. It is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Automation and Digitalization of Fish Imaging Technique Fuel North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market

An automated FISH enumeration system facilitates the automatic detection and counting of FISH signals generated by interphase nuclei in formalin-fixed, paraffin-embedded human tissue specimens. This system consists of standard hardware components, including an automated scanning microscope and an image analysis system, and software platforms with FISH assay-specific applications (apps). Automated FISH enumeration systems are designed to be used with FISH assays for IVD purposes to identify, count, and classify cells based on their size, shape, and colour. Adopting automated technologies may result in reduced hands-on time compared to manual FISH test enumeration systems. FISH is a gold standard method for diagnostics owing to the ease of use and the ability to provide same-day results after sample collection. The automation of FISH imaging with reduced probe volumes and less hands-on time is likely to further fuel the application of FISH testing in clinical and research laboratories soon, ultimately driving better patient outcomes. Integrating FISH imaging with digital pathology platforms would facilitate remote collaboration among experts and open avenues for telepathology. Advancements in imaging technologies are likely to result in higher-resolution imaging, improved fluorophores, and sophisticated image analysis algorithms, fostering precise genetic visualization and enhancing FISH imaging tools. In the future, FISH technology is anticipated to play an important role in personalized medicine, aiding in tailoring treatment strategies based on individual genetic profiles. The integration of AI and machine learning, offering insights from vast datasets and predicting disease outcomes, would further amplify the diagnostic potential of FISH imaging. Thus, automation and digitalization are likely to emerge as significant trends in the fluorescence in situ hybridization (FISH) imaging systems market.

North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Overview

The North American North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is segmented into the US, Canada, and Mexico. An increase in the prevalence of target disorders propels the need for clinical urgency alternatives, which drives the market growth in the region. The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics and the rising prevalence of genetic disorders and cancer fuel the adoption of fluorescence in-situ hybridization (FISH) imaging systems. As per data published by the American Cancer Society in 2022, in US there are around 1.9 million new cancer cases diagnosed and 609,360 cancer deaths. These systems offer high-resolution imaging of genetic material, enabling researchers and clinicians to detect chromosomal abnormalities and gene mutations with greater accuracy. Furthermore, the increasing focus on personalized medicine and targeted therapies has led to an upsurge in research activities involving genetic analysis, bolstering the demand for FISH imaging systems. The ability of these systems to provide detailed spatial information on gene sequences directly within cells has proven invaluable in both research and clinical applications. The popularity of technological advancements in FISH imaging systems, such as improved automation, higher throughput, and enhanced image analysis software, has also increased in recent years. As a result, laboratories and medical institutions are better equipped to handle larger volumes of samples and generate precise results efficiently.

North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Revenue and Forecast to 2030 (US$ Million)

North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Segmentation

The North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into product, application, end users and country.

Based on product, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

In terms of application, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Based on end user, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

By country, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented int o the US, Canada, and Mexico. The US dominated the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, and Applied Spectral Imaging are some of the leading companies operating in the North America fluorescence in-situ hybridization (FISH) imaging systems market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Target Disorders
    • 4.1.2 Increasing R&D Investments in In-Vitro Diagnostics
  • 4.2 Key Market Restraints:
    • 4.2.1 High Cost of FISH Imaging Systems and Procedures
  • 4.3 Key Market Opportunities:
    • 4.3.1 Technological Advancements in Fluorescence In Situ Hybridization Imaging
  • 4.4 Future Trends:
    • 4.4.1 Automation and Digitalization of FISH Imaging Technique
  • 4.5 Impact Analysis:

5. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - North America Market Analysis

  • 5.1 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030

6. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Instruments
    • 6.3.1 Overview
    • 6.3.2 Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Consumables
    • 6.4.1 Overview
    • 6.4.2 Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Accessories
    • 6.5.1 Overview
    • 6.5.2 Accessories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Software
    • 6.6.1 Overview
    • 6.6.2 Software: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Cancer Diagnosis
    • 7.3.1 Overview
    • 7.3.2 Cancer Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Genetic Disease Diagnosis
    • 7.4.1 Overview
    • 7.4.2 Genetic Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Infectious Disease Diagnosis
    • 7.5.1 Overview
    • 7.5.2 Infectious Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Diagnostic Laboratories
    • 8.3.1 Overview
    • 8.3.2 Diagnostic Laboratories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Contract Research Organization
    • 8.4.1 Overview
    • 8.4.2 Contract Research Organization: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Pharmaceutical And Biotechnological Companies
    • 8.5.1 Overview
    • 8.5.2 Pharmaceutical and Biotechnological Companies: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Country Analysis

  • 9.1 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
    • 9.1.1 Overview
    • 9.1.2 North America , by Country, 2022 & 2030 (%)
      • 9.1.2.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.1.1 Overview
        • 9.1.2.1.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.1.3 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.1.3.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.1.3.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.1.4 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.1.5 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.2.1 Overview
        • 9.1.2.2.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.2.3 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.2.3.1 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.2.3.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.2.4 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.2.5 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.3 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.3.1 Overview
        • 9.1.2.3.2 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.2.3.3 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.3.3.1 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.3.3.2 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.3.4 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.3.5 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)

10. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 TissueGnostics GmbH
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Agilent Technologies Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 BioGenex Laboratories Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Leica Biosystems Nussloch GmbH
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 MetaSystems Probes GmbH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Bio-View Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Thermo Fisher Scientific Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Applied Spectral Imaging
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 PerkinElmer Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Euroclone SpA
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms